Cosmos Health Q2 EPS $(0.15) Misses $(0.14) Estimate, Sales $13.21M Miss $14.55M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cosmos Health reported a Q2 EPS of $(0.15), missing the $(0.14) estimate, and sales of $13.21M, missing the $14.55M estimate. This represents a significant decrease in earnings compared to the previous year, despite a slight increase in sales.
August 20, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cosmos Health's Q2 earnings report showed a significant miss on both EPS and sales estimates, with a 1600% decrease in earnings compared to last year. This could negatively impact the stock price in the short term.
The company's Q2 EPS of $(0.15) missed the $(0.14) estimate, and sales of $13.21M missed the $14.55M estimate. The significant decrease in earnings compared to the previous year suggests potential negative sentiment among investors, likely leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100